Trough concentration of itraconazole and its relationship with efficacy and safety: a systematic review and meta-analysis

Jingru Zhang,1,2 Yiwei Liu,1 Xiaolu Nie,1 Yuncui Yu,1 Jian Gu,3 Libo Zhao1 1Clinical Research Center, Beijing Children’s Hospital, Capital Medical University, Beijing, China; 2Department of Pharmacy Administration and Clinical Pharmacy, Peking University School of Pharmaceutical Sciences,...

Full description

Bibliographic Details
Main Authors: Zhang J, Liu Y, Nie X, Yu Y, Gu J, Zhao L
Format: Article
Language:English
Published: Dove Medical Press 2018-08-01
Series:Infection and Drug Resistance
Subjects:
Online Access:https://www.dovepress.com/trough-concentration-of-itraconazole-and-its-relationship-with-efficac-peer-reviewed-article-IDR
_version_ 1819143599395176448
author Zhang J
Liu Y
Nie X
Yu Y
Gu J
Zhao L
author_facet Zhang J
Liu Y
Nie X
Yu Y
Gu J
Zhao L
author_sort Zhang J
collection DOAJ
description Jingru Zhang,1,2 Yiwei Liu,1 Xiaolu Nie,1 Yuncui Yu,1 Jian Gu,3 Libo Zhao1 1Clinical Research Center, Beijing Children’s Hospital, Capital Medical University, Beijing, China; 2Department of Pharmacy Administration and Clinical Pharmacy, Peking University School of Pharmaceutical Sciences, Beijing, China; 3Department of Pharmacy, Peking University People’s Hospital, Beijing, China Objectives: The optimum trough concentration of itraconazole for clinical response and safty is controversial. The objective of this systematic review and meta-analysis was to determine the optimum trough concentration of itraconazole and evaluate its relationship with efficacy and safety.Methods: We searched PubMed, EMBASE, Web of Science, the Cochrane Library, ClinicalTrials.gov, and three Chinese literature databases (CNKI, WanFang, and CBM). We included observational studies that compared clinical outcomes below or above the trough concentration cut-off value which we set as 0.25, 0.5, and 1.0 mg/L. The efficacy outcomes were rate of successful treatment, rate of prophylaxis failure and invasive fungal infection (IFI)-related mortality. The safety outcomes included incidents of hepatotoxicity and other adverse events.Results: The study included a total of 29 studies involving 2,346 patients. Our meta-analysis showed that compared with itraconazole trough concentrations (Ctrough) of ≥0.25 mg/L, levels of <0.25 mg/L significantly increased the incidence of IFI for prophylaxis (RR =3.279, 95% confidence interval [CI] 1.73–6.206). Moreover, the success rate of treatment decreased significantly at a cut-off level of 0.5 mg/L (RR =0.396, 95% CI 0.176–0.889). An itraconazole trough level of 1.0 mg/L was associated with hepatotoxicity and other adverse events in a review of many studies.Conclusion: An itraconazole trough concentration of 0.25 mg/L should be considered as the lower threshold for prophylaxis, and a target concentration of 0.5 mg/L should be the lower limit for effective treatment. A trough level of 1.0 mg/L is associated with increased hepatotoxicity and other adverse events (using High Performance Liquid Chromatography [HPLC]). Keywords: itraconazole, trough concentration, efficacy, safety, meta-analysis
first_indexed 2024-12-22T12:28:48Z
format Article
id doaj.art-dcd5e45367a2417a82ef2e12d7f39759
institution Directory Open Access Journal
issn 1178-6973
language English
last_indexed 2024-12-22T12:28:48Z
publishDate 2018-08-01
publisher Dove Medical Press
record_format Article
series Infection and Drug Resistance
spelling doaj.art-dcd5e45367a2417a82ef2e12d7f397592022-12-21T18:25:42ZengDove Medical PressInfection and Drug Resistance1178-69732018-08-01Volume 111283129740016Trough concentration of itraconazole and its relationship with efficacy and safety: a systematic review and meta-analysisZhang JLiu YNie XYu YGu JZhao LJingru Zhang,1,2 Yiwei Liu,1 Xiaolu Nie,1 Yuncui Yu,1 Jian Gu,3 Libo Zhao1 1Clinical Research Center, Beijing Children’s Hospital, Capital Medical University, Beijing, China; 2Department of Pharmacy Administration and Clinical Pharmacy, Peking University School of Pharmaceutical Sciences, Beijing, China; 3Department of Pharmacy, Peking University People’s Hospital, Beijing, China Objectives: The optimum trough concentration of itraconazole for clinical response and safty is controversial. The objective of this systematic review and meta-analysis was to determine the optimum trough concentration of itraconazole and evaluate its relationship with efficacy and safety.Methods: We searched PubMed, EMBASE, Web of Science, the Cochrane Library, ClinicalTrials.gov, and three Chinese literature databases (CNKI, WanFang, and CBM). We included observational studies that compared clinical outcomes below or above the trough concentration cut-off value which we set as 0.25, 0.5, and 1.0 mg/L. The efficacy outcomes were rate of successful treatment, rate of prophylaxis failure and invasive fungal infection (IFI)-related mortality. The safety outcomes included incidents of hepatotoxicity and other adverse events.Results: The study included a total of 29 studies involving 2,346 patients. Our meta-analysis showed that compared with itraconazole trough concentrations (Ctrough) of ≥0.25 mg/L, levels of <0.25 mg/L significantly increased the incidence of IFI for prophylaxis (RR =3.279, 95% confidence interval [CI] 1.73–6.206). Moreover, the success rate of treatment decreased significantly at a cut-off level of 0.5 mg/L (RR =0.396, 95% CI 0.176–0.889). An itraconazole trough level of 1.0 mg/L was associated with hepatotoxicity and other adverse events in a review of many studies.Conclusion: An itraconazole trough concentration of 0.25 mg/L should be considered as the lower threshold for prophylaxis, and a target concentration of 0.5 mg/L should be the lower limit for effective treatment. A trough level of 1.0 mg/L is associated with increased hepatotoxicity and other adverse events (using High Performance Liquid Chromatography [HPLC]). Keywords: itraconazole, trough concentration, efficacy, safety, meta-analysishttps://www.dovepress.com/trough-concentration-of-itraconazole-and-its-relationship-with-efficac-peer-reviewed-article-IDRitraconazoletrough concentrationefficacysafetymeta-analysis
spellingShingle Zhang J
Liu Y
Nie X
Yu Y
Gu J
Zhao L
Trough concentration of itraconazole and its relationship with efficacy and safety: a systematic review and meta-analysis
Infection and Drug Resistance
itraconazole
trough concentration
efficacy
safety
meta-analysis
title Trough concentration of itraconazole and its relationship with efficacy and safety: a systematic review and meta-analysis
title_full Trough concentration of itraconazole and its relationship with efficacy and safety: a systematic review and meta-analysis
title_fullStr Trough concentration of itraconazole and its relationship with efficacy and safety: a systematic review and meta-analysis
title_full_unstemmed Trough concentration of itraconazole and its relationship with efficacy and safety: a systematic review and meta-analysis
title_short Trough concentration of itraconazole and its relationship with efficacy and safety: a systematic review and meta-analysis
title_sort trough concentration of itraconazole and its relationship with efficacy and safety a systematic review and meta analysis
topic itraconazole
trough concentration
efficacy
safety
meta-analysis
url https://www.dovepress.com/trough-concentration-of-itraconazole-and-its-relationship-with-efficac-peer-reviewed-article-IDR
work_keys_str_mv AT zhangj troughconcentrationofitraconazoleanditsrelationshipwithefficacyandsafetyasystematicreviewandmetaanalysis
AT liuy troughconcentrationofitraconazoleanditsrelationshipwithefficacyandsafetyasystematicreviewandmetaanalysis
AT niex troughconcentrationofitraconazoleanditsrelationshipwithefficacyandsafetyasystematicreviewandmetaanalysis
AT yuy troughconcentrationofitraconazoleanditsrelationshipwithefficacyandsafetyasystematicreviewandmetaanalysis
AT guj troughconcentrationofitraconazoleanditsrelationshipwithefficacyandsafetyasystematicreviewandmetaanalysis
AT zhaol troughconcentrationofitraconazoleanditsrelationshipwithefficacyandsafetyasystematicreviewandmetaanalysis